Zydus Wellness Limited has informed the Exchange regarding 'disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015'.
ZYDUSWELL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Wellness Limited filed a routine compliance disclosure under SEBI's Prohibition of Insider Trading Regulations, 2015. The company's Chief Financial Officer, Mr. Umesh V. Parikh, acquired 250 equity shares of face value Rs. 2 each from the open market on March 2, 2026, for a total of Rs. 95,019. After the purchase, his holding stands at 19,005 equity shares (0.00% stake). The transaction was executed on the BSE and disclosed to the company the same day, with the stock exchange filing made on March 3, 2026. No derivative trades were involved.
This is a routine regulatory disclosure, not a negative event. The small open-market purchase by the CFO may be viewed mildly positively by retail investors as it signals insider confidence, though the quantity is very small relative to overall shareholding.